Search Results

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease

Authors: Hanger, Diane P; Seereeram, Anjan; Noble, Wendy

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1647-1666(20)

Publisher: Expert Reviews

Donepezil (aricept) as a treatment for anorexia nervosa: a very feasible therapeutic possibility

Author: Bucay, Alberto Halabe

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 5, May 2009 , pp. 569-571(3)

Publisher: Informa Healthcare

Post-marketing survey of donepezil hydrochloride in Japanese patients with Alzheimer's disease with behavioral and psychological symptoms of dementia (BPSD)

Authors: TANAKA, Toshihisa; KAZUI, Hiroaki; MORIHARA, Takeshi; SADIK, Golam; KUDO, Takashi; TAKEDA, Masatoshi

Source: Psychogeriatrics, Volume 8, Number 3, September 2008 , pp. 114-123(10)

Publisher: Blackwell Publishing

An orodispersible formulation of donepezil [Aricept Evess; Eisai] has been launched in the UK for the treatment of Alzheimer's disease

Source: Inpharma, Volume 1, Number 1573, 2007-02-03 , pp. 23-23(1)

Publisher: Adis International

Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping

Authors: Lindner, Mark; Hogan, John; Hodges, Donald; Orie, Anitra; Chen, Ping; Corsa, Jason; Leet, John; Gillman, Kevin; Rose, Gregory; Jones, Kelli; Gribkoff, Valentin

Source: Psychopharmacology, Volume 188, Number 4, November 2006 , pp. 629-640(12)

Publisher: Springer

Role of the cholinergic system in regulating survival of newborn neurons in the adult mouse dentate gyrus and olfactory bulb

Authors: Kaneko, Naoko; Okano, Hideyuki; Sawamoto, Kazunobu

Source: Genes to Cells, Volume 11, Number 10, October 2006 , pp. 1145-1159(15)

Publisher: Blackwell Publishing

Recent Developments in Natural and Synthetic Drug Research for Alzheimer's Disease

Authors: Orhan, Gurdal; Orhan, Ilkay; Sener, Bilge

Source: Letters in Drug Design & Discovery, Volume 3, Number 4, May 2006 , pp. 268-274(7)

Publisher: Bentham Science Publishers

Eisai Co Ltd has announced that there were more deaths observed in the donepezil [Aricept] group than in the placebo group

Source: Reactions, Volume 1, Number 1094, 2006-03-25 , pp. 3-3(1)

Publisher: Adis International

Eisai Co Ltd has announced that more deaths were observed in the donepezil [Aricept] group than the placebo group

Source: Inpharma, Volume 1, Number 1530, 2006-03-25 , pp. 16-16(1)

Publisher: Adis International

Therapeutic Agents for Alzheimer's Disease

Authors: Suh, Won H.; Suslick, Kenneth S.; Suh, Yoo-Hun

Source: Current Medicinal Chemistry - Central Nervous System Agents, Volume 5, Number 4, December 2005 , pp. 259-269(11)

Publisher: Bentham Science Publishers

Studies on diagnostic markers for Alzheimer's disease

Authors: URAKAMI, Katsuya; TANIGUCHI, Miyako; INOUE, Masashi; WADA-ISOE, Kenji; WAKUTANI, Yosuke; NAKASHIMA, Kenji

Source: Psychogeriatrics, Volume 5, Number 3, September 2005 , pp. 99-102(4)

Publisher: Blackwell Publishing

Drug treatment of poststroke aphasia

Author: Bakheit, AMO

Source: Expert Review of Neurotherapeutics, Volume 4, Number 2, March 2004 , pp. 211-217(7)

Publisher: Expert Reviews

Donepezil (Aricept®) for treatment of Alzheimer´s disease and other dementing conditions

Author: Geldmacher, David S

Source: Expert Review of Neurotherapeutics, Volume 4, Number 1, January 2004 , pp. 5-16(12)

Publisher: Expert Reviews

Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys

Authors: Buccafusco, Jerry; Terry, Alvin

Source: Journal of Molecular Neuroscience, Volume 24, Number 1, February 2004 , pp. 85-91(7)

Publisher: Humana Press

Cholinergic enhancement of frontal lobe activity in mild cognitive impairment

Authors: Andrew J. Saykin; Heather A. Wishart; Laura A. Rabin; Laura A. Flashman; Tara L. McHugh; Alexander C. Mamourian; Robert B. Santulli

Source: Brain, Volume 127, Number 7, July 2004 , pp. 1574-1583(10)

Publisher: Oxford University Press

Donepezil: a clinical review of current and emerging indications

Authors: Román G.C.; Rogers S.J.

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 1, 1 January 2004 , pp. 161-180(20)

Publisher: Informa Healthcare

Effects of donepezil on DOI-induced head twitch response in mice: implications for tourette syndrome

Authors: Hayslett R.L.; Tizabi Y.

Source: Pharmacology Biochemistry and Behavior, Volume 76, Number 3, December 2003 , pp. 409-415(7)

Publisher: Elsevier

Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept®) to cholinesterases

Authors: Saxena, Ashima; Fedorko, James M.; Vinayaka, C. R.; Medhekar, Rohit; Radić, Zoran; Taylor, Palmer; Lockridge, Oksana; Doctor, Bhupendra P.

Source: FEBS Journal, Volume 270, Number 22, November 2003 , pp. 4447-4458(12)

Publisher: Blackwell Publishing

Progress toward a high-affinity allosteric enhancer at muscarinic M₁ receptors

Authors: Lazareno, Sebastian; Popham, Angela; Birdsall, Nigel

Source: Journal of Molecular Neuroscience, Volume 20, Number 3, August 2003 , pp. 363-367(5)

Publisher: Humana Press

GABAA Receptor Subtype Selective Cognition Enhancers

Author: Maubach, Karen

Source: Current Drug Targets-CNS & Neurological Disorders, Volume 2, Number 4, August 2003 , pp. 233-239(7)

Publisher: Bentham Science Publishers